Stock Analysis

Analyst Forecasts Just Became More Bearish On Imeik Technology Development Co.,Ltd. (SZSE:300896)

SZSE:300896
Source: Shutterstock

The latest analyst coverage could presage a bad day for Imeik Technology Development Co.,Ltd. (SZSE:300896), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little shell-shocked. Revenue estimates were cut sharply as the analysts signalled a weaker outlook - perhaps a sign that investors should temper their expectations as well.

Following the downgrade, the most recent consensus for Imeik Technology DevelopmentLtd from its 21 analysts is for revenues of CN¥4.0b in 2025 which, if met, would be a huge 29% increase on its sales over the past 12 months. Before the latest update, the analysts were foreseeing CN¥4.4b of revenue in 2025. The consensus view seems to have become more pessimistic on Imeik Technology DevelopmentLtd, noting the measurable cut to revenue estimates in this update.

See our latest analysis for Imeik Technology DevelopmentLtd

earnings-and-revenue-growth
SZSE:300896 Earnings and Revenue Growth November 6th 2024

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Imeik Technology DevelopmentLtd's past performance and to peers in the same industry. It's pretty clear that there is an expectation that Imeik Technology DevelopmentLtd's revenue growth will slow down substantially, with revenues to the end of 2025 expected to display 23% growth on an annualised basis. This is compared to a historical growth rate of 34% over the past five years. Compare this to the 73 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 26% per year. Factoring in the forecast slowdown in growth, it looks like Imeik Technology DevelopmentLtd is forecast to grow at about the same rate as the wider industry.

The Bottom Line

The clear low-light was that analysts slashing their revenue forecasts for Imeik Technology DevelopmentLtd next year. The analysts also expect revenues to grow approximately in line with the wider market. Given the stark change in sentiment, we'd understand if investors became more cautious on Imeik Technology DevelopmentLtd after today.

But wait - there's more! At least one of Imeik Technology DevelopmentLtd's 21 analysts has provided estimates out to 2026, which can be seen for free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SZSE:300896

Imeik Technology DevelopmentLtd

Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.

Flawless balance sheet and undervalued.

Community Narratives

Leading the Game with Growth, Innovation, and Exceptional Returns
Fair Value SEK 300.00|49.2% undervalued
Investingwilly
Investingwilly
Community Contributor
Why ASML Dominates the Chip Market
Fair Value €864.91|17.633% undervalued
yiannisz
yiannisz
Community Contributor
Global Payments will reach new heights with a 34% upside potential
Fair Value US$142.00|22.5% undervalued
Maxell
Maxell
Community Contributor